About The DABOM
The DABOM is a company based in Seoul (South Korea) founded in 2021. It operates as a B2B, and SaaS. The DABOM offers products and services including Exocure TM and Exostation TM. The DABOM operates in a competitive market with competitors including Biological Dynamics, Sirnaomics, Acorda, Liquidia and Genedit, among others.
- Headquarter Seoul, South Korea
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name 주식회사 더다봄
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of The DABOM
The DABOM offers a comprehensive portfolio of products and services, including Exocure TM and Exostation TM. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Artificial exosomes for therapeutic medical applications.
System for mass-producing artificial exosomes using AI.
Funding Insights of The DABOM
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by The DABOM
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - The DABOM
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
The Dabom Comparisons
Competitors of The DABOM
The DABOM operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological Dynamics, Sirnaomics, Acorda, Liquidia and Genedit, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Proprietary lab-on-chip platform for nanoparticle isolation is offered.
|
|
| domain | founded_year | HQ Location |
RNA-based therapeutics for cancer and fibrosis are developed.
|
|
| domain | founded_year | HQ Location |
Engaged in the development and commercialization of therapies that improve neurological function.
|
|
| domain | founded_year | HQ Location |
Engineered particles & films for life and material sciences applications
|
|
| domain | founded_year | HQ Location |
Genetic medicines are delivered using polymer nanoparticle platforms.
|
|
| domain | founded_year | HQ Location |
Drug delivery systems to cell interiors are developed via nanosyringes.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about The DABOM
When was The DABOM founded?
The DABOM was founded in 2021.
Where is The DABOM located?
The DABOM is headquartered in Seoul, South Korea.
What does The DABOM do?
The DABOM is a South Korean company that utilizes microfluidics and artificial intelligence to mass-produce artificial exosomes for nanomedicine. They offer platforms like Exocure TM for therapeutics and Exostation TM for production, focusing on RD and partnerships. Based in Seoul, they participate in conferences and collaborate with institutions for exosome-based innovations, advancing healthcare technology.
Who are the top competitors of The DABOM?
The DABOM's top competitors include Sirnaomics, Arcturus Therapeutics and Acorda.
What products or services does The DABOM offer?
The DABOM offers Exocure TM and Exostation TM.